Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WellGen Obtains License to Obesity Genes - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

WellGen Obtains License to Obesity Genes

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

WellGen, Inc., New Brunswick, NJ, has signed a research contract and licensing agreement with HMGene, Inc. Under terms of the research agreement, HMGene will screen WellGen’s proprietary bioactive compounds against HMGene’s proprietary panel of genes in adipocyte development, which is the body’s natural mechanism for making fat cells. The screening process will identify new, natural bioactive compounds that will be targeted toward weight loss and the control of obesity. Any resulting products will be commercialized by WellGen.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters